Lead on Purpose

SEPTEMBER 8, 2009

And I can assure you that the advice I share with you today has stood the test of time… It helped me inspire my Weatherchem team to create the original Flapper® dispensing closure. Filed under: Integrity , Leadership , Purpose , Team Building , Trust Tagged: | Albert J. Theme: Digg 3 Column by WP Designer.

Committee 140

Committee Automotive Ethics Products 140

Harvard Business Review

FEBRUARY 16, 2017

Most businesses wouldn’t survive without driving demand for their products or services, either through marketing and advertising or through involving users so deeply in the design of the product that word of mouth spurs adoption. The same is true for social innovators. But even the most needed innovation does not sell itself.

Innovation 9

Innovation Rogers NGO Participative 9

Harvard Business Review

SEPTEMBER 23, 2014

I often hear this question when I visit companies and speak about how to make an innovative idea less terrifying to high level executives. There are plenty of pundits arguing that big companies need to innovate, and pointing out that it is difficult to do so. Have you actually seen this done?”. The skepticism is warranted.

Innovation 12

Innovation P&L Short-term Company 12

Harvard Business Review

FEBRUARY 17, 2011

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). In contrast, emerging-market VCs such as Nadathur Holdings (established in 2000 by N.S.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

MAY 7, 2015

This information improved marketing campaign targeting, as well as sales force targeting. In the pharmaceutical industry, technology is transforming the sales process. A few decades ago, pharmaceutical companies promoted their products almost entirely through personal contact by salespeople with physicians.

Trends 8

Trends Technology Pharmaceuticals Team 8

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Dr Reddy's plan is to leverage Chirotech's scientific capabilities to optimize drug development processes, thus lowering manufacturing costs and speeding time-to-market. Cambridge, U.K. facility in Cambridge Science Park.

Globalization 10

Globalization Innovation Decentralization Chemicals 10

Harvard Business Review

JUNE 13, 2016

No matter how you look at it, there have been terrible, unintended outcomes from the introduction and marketing of next-generation prescription opioids. Since 1999, three years after OxyContin was unveiled by Purdue Pharmaceuticals, the rate of drug overdoses in the U.S. And what can we learn from it?

Incentives 8

Incentives Pharmaceuticals Crisis P&L 8

Harvard Business Review

MARCH 18, 2018

Why the Pharmaceutical Industry Is Booming in Japan. Japan already enjoys the world’s second-biggest market in medical devices. percent of the 2014 global medical device market—behind the U.S. Philips, the Dutch electronics and health care corporation, is among the foreign companies attracted to Japan’s market.

Health Care 8

Health Care Industry Pharmaceuticals Content 8

Harvard Business Review

SEPTEMBER 12, 2012

The study assembles considerable evidence about the hidden business model of major pharmaceutical companies: to devote most of their research budget to developing hundreds of drugs that provide few if any advantages over existing drugs and then market them heavily to doctors and patients. But why not?

Business Model 15

Business Model Company Pharmaceuticals Price 15

Harvard Business Review

AUGUST 14, 2018

However, they have all failed in China, the world’s largest digital market. Google, for example, has succeeded in dominating many foreign markets that have radically different political systems and cultures (including Indonesia, Thailand, and Saudi Arabia). market on China. market on China.

Competitive Advantage 11

Competitive Advantage Business Model Technology Marketing 11

Harvard Business Review

OCTOBER 6, 2016

Barbara Kellerman from Harvard, Jeffrey Pfeffer from Stanford, and numerous other experts have pointed out that the development market is filled with fads — slick behavioral models and fun, engaging tools — that don’t really move the needle. The culture at GE, for example, centers on execution, simplicity, and innovation.

Leadership Pipeline 13

Leadership Pipeline Leadership After Action Review Pharmaceuticals 13

Harvard Business Review

MARCH 31, 2016

” In the article, a marketing expert explains why societal shifts would render the door-to-door salesman obsolete. Over the years, innovations in distribution, media, and technology have enabled buyers to use non-sales force channels for various steps of their buying journey. ” That 1916 prediction didn’t prove true.

B2B 8

B2B B2C Uncertainty Self-aware 8

Harvard Business Review

JUNE 14, 2017

And ease of access means ease of market entry: Emerging data providers can get on their feet quickly and create new sources of competition. How the most innovative providers are creating value. But as more data and more data providers flood the market, a competitive position based solely on data becomes impossible to defend.

Health Care 9

Health Care Levitt Pharmaceuticals Competitive Advantage 9

Harvard Business Review

NOVEMBER 27, 2013

Recent events have seen a rash of the departures from large corporates: Steve Ballmer from MicroSoft, Jeremy Levin from Teva Pharmaceutical, and Thorsten Heins from Blackberry. Donald Hambrick, a guru on CEOs and top teams, argues that long-tenured CEOs tend to grow “stale in the saddle”, ceasing to make adaptive changes.

CEO 14

CEO Long-term Welch Pharmaceuticals 14

Harvard Business Review

NOVEMBER 30, 2017

A few outlier industries (notably pharmaceuticals, medical devices, and computers) prop up the sector’s aggregate performance; most others have experienced flat growth or outright declines in real GDP over the past two decades. But now the situation has reached such a tipping point that larger U.S. manufacturers are taking notice.

Supply Chain 8

Supply Chain McKinsey Incentives Bottom-up 8

Harvard Business Review

MAY 8, 2013

I recently conducted a study of 56 randomly selected companies involved in major change and innovation efforts in the high-tech, retail, pharmaceutical, banking, automotive, insurance, energy, non-profit, and health care industries. Nearly 68% of these large-scale change and innovative efforts failed.

Middle Management 9

Middle Management Management Automotive Pharmaceuticals 9

Harvard Business Review

JUNE 16, 2011

So it is with most breakthrough innovations and banner financial years. Investors grapple daily in an effort to figure out how to value companies whose accounting assets — things like land, capital, products, and licenses — don't adequately express their true market value. If ego and time allow, the list can be quite long.

Intangible Assets 15

Intangible Assets Analysis Pharmaceuticals Innovation 15

Harvard Business Review

JANUARY 8, 2013

Breaking down functional silos is key to everything from encouraging communication to building valuable connections to sparking innovation. arm of pharmaceuticals manufacturer Boehringer Ingelheim (BIPI). Among the first 100 participants: BIPI's CEO, who was matched with a young member of one of the brand marketing teams. "A

Company 9

Company Pharmaceuticals Health Care Participative 9

Harvard Business Review

OCTOBER 22, 2013

Innovation starts with new and novel ideas. When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. Finding ideas is never the problem — initially. Find Pivots.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

DECEMBER 5, 2016

Library leaders knew that given the immense changes brought on by digital innovations, as well as shifts in the communities that the Library served, it would need to evolve. Innovation communities had been used by Best Buy to grow its portion of the women’s consumer electronics market by $4.4b in less than five years.

Library 8

Library Strategy Reference Bottom-up 8

Harvard Business Review

FEBRUARY 4, 2013

Just under 1,000 companies account for half of the world's market capitalization, Eccles notes. Our research with members of the global C-suite, and with leading sustainability and innovation experts, has identified seven vectors of breakthrough change. Perhaps surprisingly, two leading examples come from pharmaceutical companies.

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

APRIL 19, 2016

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. Innovation, customization, speed, and location are also among the opportunities it offers. What would be the cost/benefit of flattening your supply chain and moving production closer to your markets?

Supply Chain 8

Supply Chain Execution Analysis Technology 8

Harvard Business Review

JUNE 16, 2016

To understand the nature of the problem, let’s look at how penicillin was brought to market. The Institute for Applied Cancer Science at MD Anderson (IACS) is exploring revolutionary new cures and the National Network for Manufacturing Innovation (NNMI) is working to revive the US production capacity. The Valley of Death.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

DECEMBER 23, 2016

Heat degrades the substrate of innovation, while light catalyzes it.” We see similar findings in research looking at individual work teams. Lilly’s research shows these same effects can happen between members of alliance innovation teams. Focus your conflict-management resources where it matters most.

Productivity 8

Productivity Products Survey Strategic Fit 8

Harvard Business Review

DECEMBER 14, 2015

As CEO of the TLEX Institute, Johann Berlin specializes in bringing mindfulness training to CEOs and corporate teams. They want to see how these approaches … are truly beneficial to existing priorities like retention, talent advancement, innovation.” ” You and Your Team. The trading desk was an organized riot.

CEO 8

CEO Emotional Intelligence Cooper Pharmaceuticals 8

Harvard Business Review

APRIL 13, 2015

Warren Buffett has earned his nickname because he’s proven time and again that he has an eye for predicting how markets will change and which companies will succeed in the aftermath. When markets or technologies change, it often requires entire segments of the value network to be reimagined. What’s changed?

Software 8

Software Trends Mass Marketing Marketing 8

Harvard Business Review

SEPTEMBER 7, 2015

Hiring policies influence morale, productivity and turnover, marketing efforts shape demand growth, and competitors fight back. Games will further reinforce this edge over books or seminars once VR (virtual reality) becomes fully market-ready. Strategy games anticipate and amplify reality by acting like vaccinations.

Seminar 8

Seminar Learning Curve Strategy Comparison 8

Harvard Business Review

SEPTEMBER 20, 2013

Content Innovation. Or a healthcare data offering evaluating physicians’ perceptions on a new drug may be useful not only to brand managers at pharmaceutical companies, but also to portfolio managers at asset management firms seeking to find promising investment opportunities. In some cases, they’re right.

Execution 8

Execution Metrics Content Christensen 8

Harvard Business Review

SEPTEMBER 4, 2015

Innovation is widely regarded as important to long-term business performance. We’ve found that CEOs of big pharmaceutical companies, for example, are more likely to have a background as company lawyers, salespeople, or finance managers, than one in medicine or pharmaceutical R&D. Overall, it is a messy picture.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

OCTOBER 27, 2015

In most companies, marketers are in charge of assessing the competition. Because of this, close to 60 percent of all competitive intelligence professionals report to marketing. Yet the majority of marketers fail to use their competition analysts strategically, instead using them to gather more “recon” data.

Marketing 8

Marketing Competitive Intelligence Porter How To 8

Harvard Business Review

OCTOBER 11, 2013

Four years ago, Craig Hatkoff, co-founder of the Tribeca Film Festival, approached me about a brainstorm: an event recognizing and celebrating breakthrough innovators. When I suggested to Clayton Christensen that we partner with Hatkoff to create the Tribeca Disruptive Innovation Awards , Clay’s response was : I trust you Whitney.

Innovation 11

Innovation Christensen Decisionmaking CTO 11

Harvard Business Review

SEPTEMBER 3, 2013

Hilde Dach, the former chief scientist at drug-development start-up Genbac and now a team leader at German pharmaceuticals maker Caliska, which had acquired Genbac, could read disappointment in the face of Johan Greve, the Caliska division head who was her boss. You''ve always seen it as a pharmaceutical product. Hey," he said.

Case Study 8

Case Study Pharmaceuticals Bottom-up Marketing 8

Harvard Business Review

NOVEMBER 29, 2016

The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development. Innovating for Value in Health Care. Insight Center. Sponsored by Medtronic.

Pharmaceuticals 8

Pharmaceuticals Incubator Health Care Biotechnology 8

Harvard Business Review

JUNE 23, 2015

When I was in the midst of researching what caused cross-functional teams to succeed — and finding that many of them failed — I discovered a deeply dysfunctional development project in a huge multinational IT company. ” This is just one example of the dysfunction that exists in cross-functional teams. Leading Teams.

Team 8

Team Project Software Engineering 8

Strategy Driven

JANUARY 24, 2011

Closing the Execution Gap : How Great Leaders and Their Companies Get Results by Richard Lepsinger If an organization can’t execute its plans and initiatives, nothing else matters: not the most solid, well thought-out strategy, not the most innovative business model, not even technological breakthroughs that could transform an industry.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Harvard Business Review

MARCH 8, 2011

If you can reinforce that focus in every decision you make — from mergers & acquisitions to new product launch to budgeting or cutting costs — it can help you win market share, generate sustainable growth, or even turn around a decline. Are we focused strategically on markets where we can compete effectively?

Merchandising 15

Merchandising Budgeting Pharmaceuticals CEO 15

Harvard Business Review

MAY 10, 2013

As noted management expert Geoffrey Moore told me with respect to high-velocity competition, "I''m not sure you ever want to be in the public markets." Its RAZR thin phone was a huge success in the mid-2000''s, and the market raved. Take Motorola, for instance. Take Motorola, for instance.

Venture Capitalist 8

Venture Capitalist Restructuring Competitive Advantage Short-term 8